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__________________________________________________________________________26 
ABSTRACT 27 
  28 
Sodium caseinate (NaCN) was incubated prior to and after hydrolysis with a microbial 29 
transglutaminase (TGase) and hydrolysed with Prolyve 1000. The resultant hydrolysates were 30 
tested for their immunomodulatory and antioxidant activity. TGase-treated hydrolysates 31 
significantly reduced (p < 0.05) the production of IL-6 at 0.5 and 1 mg mL-1 and the non-32 
TGase treated hydrolysate reduced the production of IL-6 at 1 mg mL-1 in concanavalin 33 
(ConA) stimulated Jurkat T cells. None of the samples had an effect on IL-2. The 34 
hydrolysates showed higher oxygen radical absorbance capacity assay and ferric reducing 35 
antioxidant power activity than unhydrolysed NaCN, but no significant (p > 0.05) differences 36 
were found between the TGase-treated and non-TGase-treated samples. In the presence of 37 
hydrogen peroxide, the non-TGase-treated sample exhibited the highest DNA protective 38 
effect in U937 cells. These findings suggest that NaCN derived hydrolysates with and 39 
without treatment with TGase may exert specific antioxidant, genoprotective and anti-40 
inflammatory effects. 41 
___________________________________________________________________________ 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
  50 
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1. Introduction 51 
 52 
Approximately 30% of occidental population deaths are due to diseases related to 53 
cardiovascular problems (WHO, 2011). The continuous exposure to chemicals, unhealthy 54 
diets and sedentary life-style may be contributing factors for premature ageing and illness. 55 
Oxidative stress is an imbalance between the production of free radicals or reactive oxygen 56 
species (ROS) and the neutralisation of these by antioxidant compounds (Lobo, Patil, Phatak, 57 
& Chandra, 2010). The excess of ROS produced as a result of oxidative stress is involved in 58 
the pathogenesis of neurodegenerative, cardiovascular and inflammatory diseases. For 59 
instance, atherosclerotic cardiovascular disease is characterised by the oxidation of low-60 
density lipoproteins (LDL) which induce the adhesion and influx of monocytes and lead to 61 
cytokine production, a pro-inflammatory response (Singh, Devaraj, & Jialal, 2005). Some 62 
multifactorial diseases such as atherosclerosis or Parkinson’s disease are the result of 63 
combined inflammatory and oxidative processes (Chen, Lü, Yao, & Chen, 2016). For this 64 
reason, there is an increasing interest in studies on the anti-inflammatory and antioxidant 65 
potential of bioactive dietary ingredients. 66 
 Bioactive peptides (BAPs) are natural protein fragments obtained from food proteins 67 
such as dairy, eggs, fish, meat or vegetables. These peptides can be released from proteins by 68 
bacterial fermentation, digestion or enzymatic hydrolysis and they may possess potent 69 
bioactivities (Korhonen & Pihlanto, 2006; Nongonierma, O’Keeffe, & FitzGerald, 2016). 70 
Antioxidant BAPs may inhibit the action of free radicals, reducing oxidation events and 71 
thereby contribute to the prevention of inflammatory responses. Antioxidant and anti-72 
inflammatory bioactivities are directly related (Pashkow, 2011). Caseins from bovine milk 73 
contain a large number of bioactive peptides encrypted into the parent protein (Hernández-74 
Ledesma, García-Nebot, Fernández-Tomé, Amigo, & Recio, 2014; Nongonierma & 75 
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FitzGerald, 2015; Nongonierma et al., 2016; Phelan, Aherne, FitzGerald, & O'Brien, 2009a; 76 
Power, Jakeman, & FitzGerald, 2012; Wada & Lönnerdal, 2014). The composition, structure, 77 
hydrophobicity, position of amino acid residue and molecular mass are factors directly 78 
related with the activity of BAPs (Chen, Muramoto, Yamauchi, Fujimoto, & Nokihara, 79 
1998). The amino acid composition of casein, which is rich in Pro residues, makes it a 80 
potential source of bioactive peptides for the production of biofunctional foods (Pihlanto, 81 
2006). 82 
 Enzymatic hydrolysis of casein proteins has resulted in the generation of BAPs with 83 
demonstrated immunomodulatory and antioxidant activities. Two casein hydrolysates, 84 
deriving from digestion with Lb. helveticus MIMLh5 and Lb. acidophilus ATCC 4356 85 
proteinases, demonstrated anti-inflammatory activity by decreasing NF-κB activity in 86 
recombinant Caco-2 cells (Stuknyte, De Noni, Guglielmetti, Minuzzo, & Mora, 2011). A 87 
recent study demonstrated that a <5 kDa NaCN hydrolysate was able to reduce IL-8, a pro-88 
inflammatory cytokine, in tumour necrosis factor-alpha (TNF-α) treated Caco-2 cells, and 89 
similar results were observed ex vivo in porcine colonic tissue (Mukhopadhya et al., 2015). 90 
Similarly, a peptide obtained from β-CN (f 94-98), QEPVL, and its derivative, QEPV, 91 
showed the capacity to regulate the inflammatory process not only in vitro but also in vivo in 92 
Balb/c mice (Jiehui et al., 2014). Studies using Balb/c mice reported that yak casein 93 
hydrolysates possessed radical scavenging activities against 2,2-Diphenyl-1-picrylhydrazyl 94 
(DPPH), superoxide and hydrogen peroxide, and also decreased the production of nitric oxide 95 
(NO) and the pro-inflammatory IL-6 and IL-1β cytokines (Mao, Cheng, Wang, & Wu, 2011). 96 
The antioxidant properties of casein hydrolysates have been widely reviewed (Pihlanto, 2006; 97 
Power et al., 2012). 98 
Furthermore, the combination of cross-linking and enzymatic hydrolysis in casein 99 
may lead to the generation of novel peptides with new bioactivities due to the intra and inter 100 
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cross-links created within the casein peptide structure. Cross-linking with TGase is known to 101 
improve the physicochemical and organoleptic properties of dairy products. The addition of 102 
TGase improved the emulsifying and foaming properties of NaCN (Flanagan & FitzGerald, 103 
2003). The application of TGase in yoghurt and cheese is well established leading to 104 
improved product quality (Özer, Hayaloglu, Yaman, Gürsoy, & Şener, 2013; Romeih, Abdel-105 
Hamid, & Awad, 2014). However, little is known about the effect of TGase on the bioactivity 106 
of peptides. A recent study by Hong, Gottardi, Ndagijimana, and Betti (2014) found that 107 
glycopeptides from fish, obtained by glycosylation and proteolytic hydrolysis with Alcalase, 108 
improved their cellular antioxidant activity in HepG2 cells and their lipid oxidation inhibition 109 
activity with the addition of TGase. Additionally, gluten hydrolysates glycosylated with 110 
TGase, have been reported to improve their in vitro antioxidant activity (Gottardi, Hong, 111 
Ndagijimana, & Betti, 2014). Preliminary work in our laboratory has shown that samples 112 
treated with TGase prior to hydrolysis had an anti-inflammatory activity in LPS induced 113 
Jurkat T cells; however, no antioxidant activity was detected  (O’Sullivan, Lahart, 114 
O’Callaghan, O’Brien, & FitzGerald, 2013). 115 
 The aim of the present study was to assess the effect of enzymatic hydrolysis and its 116 
combination with TGase cross-linking treatment on the immunomodulatory and antioxidant 117 
activity of NaCN hydrolysates. 118 
 119 
2. Materials and methods 120 
 121 
2.1. Materials 122 
 123 
Sodium caseinate (NaCN; 87.57%, (w/w, protein) was provided by Arrabawn Co-op 124 
Society Ltd., Tipperary, Ireland. Calcium independent TGase from Streptoverticillium spp. 125 
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was provided by Forum Products Ltd. (Brighton Rd., Redhill, Surrey, UK). Prolyve 1000™ 126 
was kindly provided by Lyven Enzymes Industrielles (Caen, France).  U937 and Jurkat T 127 
cells were obtained from the European Collection of Animal Cell Cultures (ECACC, 128 
Salisbury, Wilts, UK). MTT I proliferation kit was obtained from Roche Diagnostics 129 
(Burgess Hill, West Sussex, UK). IL-6 and IL-2 eBioscience enzyme-linked 130 
immunoadsorbent assay (ELISA) Ready-SET-Go kits were purchased from Insight 131 
Biotechnology (Wembley, UK). All other chemicals and reagents were purchased from 132 
Sigma Chemical Company Ltd. (Wicklow, Ireland), unless otherwise stated. 133 
 134 
2.2. Generation of cross-linked NaCN hydrolysates 135 
 136 
TGase-treated hydrolysates were generated prior to (TGase/Prolyve) and after 137 
(Prolyve/TGase) Prolyve hydrolysis. For the generation of the Prolyve/TGase hydrolysate 138 
sample a NaCN solution (10%, w/v) was incubated with 0.3% (v/v) Prolyve 1000™ at 50 °C 139 
and pH 7 using a pH stat (Titrando 843, Metrohm, Dublin, Ireland). After 240 min of 140 
incubation, the enzymatic reaction was stopped by heating at 80 °C for 20 min. An aliquot of 141 
this solution was used as a non-TGase-treated hydrolysate (Prolyve). Then the resultant 142 
solution was incubated with TGase (2%, v/v) at room temperature and pH 7.0 for 180 min. 143 
Inactivation of TGase was carried out by heating at 80 °C for 20 min. For the generation of 144 
the TGase/Prolyve hydrolysate sample, NaCN was incubated firstly with TGase (2%, v/v) 145 
and subsequently submitted to hydrolysis with Prolyve 1000™ using the same conditions as 146 
outlined above.  All the hydrolysates generated where further subjected to in vitro digestion 147 
with pepsin (enzyme:substrate ratio 1:40, w/w) for 90 min at 37 °C at pH 2.0 and 148 
subsequently with Corolase PP® (enzyme:substrate ratio 1:10, w/w) for 180 min at 37 °C at 149 
pH 7 to simulate in vitro gastrointestinal digestion (SGID; Walsh et al., 2004). 150 
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 151 
2.3. Cell culture 152 
  153 
A leukaemic monocytic lymphoma cell line, U937 cells, and a human leukaemic T 154 
cell line, Jurkat T cells, were maintained at 37 °C in a 5% CO2 atmosphere, in antibiotic-free 155 
medium (RPMI-1640) supplemented with 10% foetal bovine serum (FBS). Reduced serum 156 
media (2.5% FBS) was used during experiments. 157 
 158 
2.4. Cell viability assay 159 
  160 
Cells at a density of 1×105 cells mL‒1 in growth media were seeded in each well of 96-161 
well flat-bottom plates. Cells were incubated with hydrolysates (0–50 mg mL-1) at 37 °C for 162 
24 h. Following incubation, cell viability was determined using the MTT [3-(4,5-163 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Briefly, media was removed 164 
(100 µL) and MTT reagent 1 (5 µL) was added and cells were incubated for 4 h at 37 °C. 165 
Then, MTT reagent 2 (100 µL) was added to the cells and the plate was incubated overnight 166 
at 37 °C. The absorbance was measured on a Varioskan Flash microplate reader 167 
(ThermoScientific, Tewksbury, MA, USA) at 570 nm. The half maximal effective 168 
concentration (EC50) values were calculated in triplicate (n = 3) and expressed as mg mL-1 169 
using GraphPad Prism 4. 170 
 171 
2.5. Immunomodulatory activity – cytokine production 172 
 173 
Jurkat T cells, at a density of 2 × 105 cells mL‒1, were seeded in 96-well plates in the 174 
presence of concanavalin A (ConA, 50 µg L-1) and were incubated with test samples at 0.5 175 
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and 1 mg mL-1 for 24 h at 37 °C. Production of the cytokines IL-6 and IL-2 was determined 176 
using ELISA kits. Absorbance was read at 450 nm using a microplate reader. Experiments 177 
were performed in triplicate (n = 3) and data were expressed as a percentage of the stimulated 178 
cell control. 179 
 180 
2.6. Antioxidant activity 181 
 182 
2.6.1. Intracellular reduced glutathione (GSH)  183 
 U937 cells (1 × 105 cells mL-1, 5mL) were incubated with NaCN and its hydrolysates 184 
(0.5%, v/v) in a 96 well plate for 24 h at 37 °C. Following incubation, cells were harvested, 185 
sonicated on ice at 13 mA for 30 s, centrifuged (14,000 × g, 30 min, 4 °C) and the supernatant 186 
was collected. An aliquot (100 µL) of sample was mixed with 0.01 M sodium phosphate-187 
0.005 M ethylenediamine tetraacetic acid buffer (1.8 mL) and o-phthaldialdehyde (0.1 mg). 188 
The fluorescence was determined at 350 nm (absorption) and 420 nm (emission). The GSH 189 
content was determined from a standard curve using known concentrations of GSH and the 190 
results were expressed relative to the protein content. The protein content of the samples was 191 
determined by the bicinchoninic acid (BCA) protein assay as previously described by Smith 192 
et al. (1985).  The assay was performed in triplicate (n = 3). 193 
 194 
2.6.2. Comet assay 195 
 U937 cells (1 × 105 cells mL-1) were treated with 5 mg mL-1 (0.5%, v/v) of test sample 196 
for 24 h in a 6-well plate (final volume 2 mL) at 37 °C. After incubation, cells were treated 197 
with 50 µM H2O2 or 400 µM tert-butyl hydroperoxide (t-BOOH) for 30 min. The comet assay, 198 
previously described by McCarthy et al. (2012),  was then used to measure oxidative DNA 199 
damage. Cells were harvested and transferred to microscope slides (prepared with normal 200 
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gelling agarose; NGA) and covered with low melting point agarose (LMP). The slides were 201 
placed in lysis solution for 1 h at 4 °C, followed by electrophoresis at 300 mA, 20 V for 25 202 
min. The slides were then neutralised using 0.4 M Tris-base at pH 7.5 and stained with 203 
ethidium bromide (20 µg mL-1). Cells were visualised under a fluorescence microscope and 204 
Komet 5.5 image analysis software was used to score 50 cells per slide. The DNA damage 205 
was performed in quadruplicate (n = 4) and expressed as percentage of tail DNA. 206 
 207 
2.6.3. Oxygen radical absorbance capacity assay  208 
The oxygen radical absorbance capacity (ORAC) assay was performed as described 209 
by Zulueta, Esteve, and Frígola (2009) using a Synergy™ HT plate reader (BioTek 210 
Instruments Limited, Bedfordshire, UK). An aliquot (50 µL) of test sample (0.1 mg mL-1), 211 
standard or phosphate buffer (75 mM) and 50 µL of fluorescein (0.78 µM) were added into a 212 
microtitre plate incubated at 37 °C. The reaction was started with the addition of 25 µL of 213 
2.2’-azobis-2-methyl-propanimidamide (AAPH) to each well. Fluorescence readings were 214 
recorded every 5 min for 120 min at excitation and emission wavelengths of 485 and 520 nm, 215 
respectively. The ORAC values, expressed as µmoles trolox equivalents (TE) per mg freeze 216 
dried sample, were calculated using trolox as a standard. Experiments were performed in 217 
triplicate (n = 3).  218 
 219 
2.6.4. Ferric reducing antioxidant power activity 220 
The ferric reducing antioxidant power (FRAP) value of hydrolysate samples was 221 
determined using the method described by Benzie and Strain (1999) with some 222 
modifications. Briefly, 2 mL of freshly prepared FRAP reagent [150 µL; 0.3 M acetate buffer 223 
(pH 3.6), 0.01 M 2,4,6-tripyridyl-s-triazine (TPTZ), 0.02 M FeCl3⋅6H2O 10:1:1] heated  to 224 
37 °C was added into a cuvette  and the absorbance was read at 590 nm. Test sample 225 
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(100 µL), FeSO4 (standard) and MeOH (blank) was then added and the absorbance (590 nm) 226 
was read after 30 min incubation at 37 °C.  The experiment was performed in triplicate (n = 227 
3) and the FRAP values (µM) were calculated from the standard curve. 228 
 229 
2.6.5. 2.2’-Azino-bis(3-ethylbenzothiazoline-6-sulphonate) radical scavenging assay  230 
 The 2.2’-azino-bis(3-ethylbenzothiazoline-6-sulphonate) (ABTS+) radical scavenging 231 
activities were measured using the previously described method by Re et al. (1999). The 232 
ABTS•+ solution was prepared by mixing 7 mM ABTS with 2.45 mM potassium persulphate 233 
for 16 h to generate the radicals. The radical solution was then diluted to an absorbance of 234 
0.70 ± 0.02 at 734 nm. Test samples (10 µL) at a final concentration 1 mg mL-1 were added in 235 
a 96 well plate with the radical solution (200 µL) and kept in the dark at room temperature 236 
for 5 min. Absorbance was then measured at 734 nm. Known concentrations of trolox 237 
solutions were used to plot a standard curve and ABTS+ values were calculated. All samples 238 
were analysed in triplicate (n=3) and the final inhibitory activity was expressed as %ABTS 239 
inhibition using the following equation: 240 
   ABTS inhibitory activity (%) = [(Absblank - Abssample) / Absblank] × 100 241 
 242 
2.6.6. DPPH radical scavenging assay 243 
The DPPH assay was carried out according to the method described by Brand-244 
Williams, Cuvelier, and Berset (1995). Concentrations of trolox ranging from 0.04 to 0.40 µM 245 
were used to prepare a standard curve for calibration. Hydrolysate test samples (100 µL) at a 246 
final concentration 1 mg mL-1 were diluted with methanol and incubated with 3.9 mL of 6 µM 247 
DPPH reagent for 30 min. Absorbance was read at 515 nm at 0 and 30 min. All samples were 248 
analysed in triplicate (n=3) and the results were expressed as % DPPH inhibition using the 249 
following equation: 250 
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DPPH inhibition (%) = [(Absblank - Abssample) / Absblank] × 100 251 
 252 
2.7. Statistical analysis 253 
  254 
All data were determined as the mean and standard error values of at least three 255 
independent experiments. Data were analysed by one-way analysis of variance (ANOVA) 256 
followed by Dunnett's test (or Tukey's multiple comparison test, where appropriate), using 257 
Graph-Pad Prism 4 (Graph-Pad software, California, U.S.A.). 258 
 259 
3. Results and discussion 260 
 261 
3.1. Effect of casein hydrolysates on cell viability  262 
 263 
Cell viability of Jurkat T (Table 1) and U937 (Table 2) cells was measured by the 264 
MTT assay to determine non-toxic concentrations of hydrolysates to be used for subsequent 265 
experiments. The MTT assay measures cellular mitochondrial activity by assessing the 266 
activity of mitochondrial reductase. Cells were incubated with increasing concentrations of 267 
NaCN and its hydrolysates (0–5%, v/v, equivalent to 0–50 mg mL-1). The EC50 values were 268 
calculated and represent the concentration required that inhibits cell viability by 50%. Based 269 
on the EC50 values obtained, the hydrolysates seemed to have similar cytotoxic effects on 270 
Jurkat T and U937 cells (Table 3). McCarthy et al. (2013) reported the cytotoxic effect of 271 
brewers’ spent grain (BSG) hydrolysates on U937 cells was higher than on Jurkat T cells.  In 272 
the present study, samples at 0.5% (v/v) showed significant (p < 0.05) inhibition of the 273 
viability of Jurkat T cells compared with control (non-treated cells) supporting the previous 274 
results from Lahart et al. (2011). Lahart et al. (2011) reported that a NaCN hydrolysate at 275 
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0.25% (v/v), obtained with Alcalase (A4), decreased the viability of Jurkat T cells to 61.2% 276 
compared with untreated cells (100%). All the hydrolysates studied herein induced a 277 
significant (p < 0.05) cytotoxic activity at concentrations of 0.5% (v/v) in Jurkat T cells. In a 278 
study by Phelan, Aherne-Bruce, O'Sullivan, FitzGerald, and O'Brien (2009b), NaCN 279 
hydrolysates prepared using different food-grade enzyme preparations were cytotoxic to 280 
Jurkat T cells at a concentration of 0.5% (v/v). The addition of  100 µg mL-1 of a 281 
glycomacropeptide from bovine milk was reported to significantly inhibit the viability of 282 
U937 cells (Li & Mine, 2004). In contrast, in our study concentrations of the hydrolysates up 283 
to 5 mg mL-1 (corresponding to 0.5%, v/v), showed no inhibition in the viability of U937 284 
cells. The conformation, degree of hydrolysis and the source of the proteolytic enzyme used 285 
to generate the hydrolysates are key factors that may affect the cytotoxicity of hydrolysates 286 
(Lahart et al., 2011; Zou, He, Li, Tang, & Xia, 2016). TGase treated hydrolysates showed 287 
similar results in Jurkat T cells to those reported by O’Sullivan et al. (2013). Sample 288 
concentrations that showed a cell viability < 75% of control were considered toxic. 289 
Therefore, non-toxic test sample concentrations of 0.5 and 1 mg mL-1 were used for 290 
subsequent immunomodulatory and antioxidant activities in both cell lines.  291 
 292 
3.2. Immunomodulatory effects of NaCN hydrolysates 293 
  294 
The anti-inflammatory activity of intact NaCN, the NaCN hydrolysate (Prolyve) and 295 
the cross-linked hydrolysates (TGase/Prolyve and Prolyve/TGase) was screening by 296 
measuring their potential to supress the production of IL-2 and IL-6 in ConA stimulated 297 
Jurkat T cells. ConA is a lectin mitogen known for its ability to stimulate the T-cell receptor 298 
and the subsequent activation of signalling pathways involving nuclear factor of activated T-299 
cells (NFAT) and mitogen-activated protein kinase (MAPK) pathways resulting in the 300 
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production of cytokines (Takahashi et al., 2009; Tanaka, Akaishi, Hosaka, Okamura, & 301 
Kubohara, 2005). The results showed that all hydrolysates tested significantly reduced (p < 302 
0.05) IL-6 production (Table 4). This effect was dose dependent.  IL-6 production was 303 
significantly decreased (p < 0.05) by NaCN up to 41.85 and 30.21% of the control ConA-304 
stimulated cells at concentrations of 0.5 and 1 mg mL-1, respectively. In contrast, a study 305 
using yak casein showed that intact casein did not produce a decrease in IL-6, whereas its 306 
hydrolysates decrease cytokine production in LPS-stimulated macrophages (Mao et al., 307 
2011). The production of cytokines in LPS-induced RAW cells incubated with yak casein 308 
hydrolysates has been previously reported by Mao et al. (2011). The study reported that at a 309 
concentration of 0.5 mg mL-1 the hydrolysates significantly inhibited the production of the 310 
pro-inflammatory cytokines IL-6, IL-1β and TNF-α. A recent study showed similar results in 311 
ConA induced Jurkat T cells incubated with NaCN hydrolysates whereby IL-6 cytokine 312 
production was significantly decreased compared with the control whereas IL-2 production 313 
was unchanged (O'Sullivan, O'Callaghan, O'Keeffe, FitzGerald, & O'Brien, 2015). In an 314 
earlier study, Phelan et al. (2009b) studied the effect of eight distinct casein hydrolysates 315 
generated with several food-grade enzyme preparations on IL-2 production in Con-A induced 316 
Jurkat T. The study demonstrated that six of the hydrolysates enhanced the secretion of IL-2. 317 
The authors suggest that this pro-inflammatory effect might be useful on regulation of 318 
deficient immune processes. Yak casein hydrolysates were also reported to increase IL-2 319 
production in ConA stimulated spleen cells (Mao, Yang, Song, Li, & Ren, 2007). 320 
Nevertheless, in the present study, NaCN and its hydrolysates did not have any effect on 321 
ConA stimulated IL-2 production in Jurkat T cells.  NaCN at 1 mg mL-1 significantly reduced 322 
the production of IL-2 (79%) compared with the control (Table 4). Similarly, Lahart et al. 323 
(2011) found no difference in the secretion of IL-2 in Jurkat T cells incubated with 0.5% 324 
(v/v) of intact NaCN or 0.5% (v/v) of NaCN hydrolysates generated with Alcalase and 325 
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Flavourzyme. However, O’Sullivan et al. (2013) reported a decrease in IL-2 production in 326 
ConA-stimulated Jurkat T cells incubated with NaCN cross-linked with TGase pre-327 
hydrolysis. The extent of hydrolysis reached and the enzymatic preparation used to generate 328 
the hydrolysates are mainly responsible for the final sequences of peptides within the 329 
hydrolysates and could induce different cell reactions.  It is interesting to note a study where 330 
the substitution of proline in short peptides had a negative effect on their immunomodulatory 331 
activity, but the substitution of proline with proline analogues did not have an impact on the 332 
final bioactivity.  The study reported on an immunomodulatory peptide from β-casein (191–333 
209) (LLYQEPVLGPVRGPFPIIV) which was synthesised with modifications around Pro 334 
residues. In particular, substitution of the last proline (P206) with D-Pro produced an 335 
inhibition in the in vitro immunosuppressory effects in α-CD3 and α-CD28 stimulated murine 336 
spleen cells (Bonomi et al., 2011). Hence, the structure and sequence of peptides is a crucial 337 
factor which directly affects their anti-inflammatory activity. 338 
 339 
3.3. Cellular antioxidant assays 340 
  341 
Reduced GSH, an important antioxidant, is produced within the cells to prevent cell 342 
damage induced by ROS. Incubation with the NaCN hydrolysates led to a small increase in 343 
GSH concentration in U937 cells, whereas the parent protein, unhydrolysed NaCN, produced 344 
a reduction of the GSH content (Table 5). However, none of the results was statistically 345 
significant compared with the untreated cells. These results are in agreement with those 346 
reported by O’Sullivan et al. (2013) where no difference in GSH content was found in 347 
TGase-treated NaCN hydrolysates in Jurkat T cells. In contrast, GSH content and catalase 348 
activity were increased by NaCN hydrolysates in Jurkat T cells (Lahart et al., 2011; Phelan et 349 
al., 2009b). Some studies suggest that the peptide profile affects its antioxidant activity. For 350 
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instance, peptides from whey protein hydrolysates had a more effective protecting ability 351 
against oxidative stress in PC12 cells as their hydrophobicity increased (Zhang et al., 2015). 352 
The hydrophobicity of the peptide residues enhances the accessibility of the peptide to the 353 
fatty acids in cell membranes, which are subjected to oxidation by free radicals and ROS 354 
(Aluko, 2012). The proteolytic enzyme used to obtain the hydrolysates is another key factor 355 
in hydrolysate bioactivity. For instance, Alcalase hydrolysates from casein efficiently 356 
increased the intracellular antioxidant enzymes superoxide dismutase (SOD) and catalase 357 
(CAT) in H2O2 treated HepG2 cells (Xie, Wang, Ao, & Li, 2013). Casein phosphopeptides 358 
(CPP), obtained by SGID, produced an increase in GSH and CAT activity in H2O2 stimulated 359 
Caco-2 cells (García-Nebot, Cilla, Alegría, & Barberá, 2011). Prolyve and Alcalase, are food-360 
grade proteolytic enzyme preparation obtained from Bacillus licheniformis and both have 361 
subtilisin activity. However, only Alcalase possesses glutamyl endopeptidase activity and is 362 
consequently able to yield higher extents of hydrolysis than Prolyve (Spellman, Kenny, 363 
O'Cuinn, & Fitzgerald, 2005). Thus, the generation of peptides with different proteinases 364 
produces distinctive peptide profiles and therefore this may explain the differing results.  365 
 366 
3.4. Genoprotective effect of casein hydrolysates 367 
  368 
The ability of the samples to protect against oxidant-induced DNA damage was 369 
determined by the comet assay also called single cell gel electrophoresis. This method 370 
measures deoxyribonucleic acid (DNA) strand breaks in the cells. The oxidants used, t-371 
BOOH (Fig.1a) and H2O2 (Fig. 1b), significantly increased the percentage of DNA damage 372 
(% DNA tail). None of the samples decreased the DNA damage induced by t-BOOH 373 
(Fig.1a). The Prolyve hydrolysate protected against the genotoxic effects of H2O2 (p < 0.05). 374 
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The rest of the hydrolysates and NaCN were not significantly different from the mean value 375 
obtained for H2O2 treatment (Fig.1b).  376 
This result may be due to the different mechanisms of action of the two oxidants. 377 
H2O2 induced cell oxidation is produced by the release of hydroxyl radicals (OH·) and it is an 378 
iron dependent reaction, whereas t-BOOH produces lipid peroxidation and it is not iron 379 
dependent. Previous studies have shown that casein hydrolysates had no effect on DNA 380 
damage induced by H2O2 in Caco-2 cells (Phelan et al., 2009b). However, several 381 
investigations have shown the genoprotective results of food-derived hydrolysates. The 382 
enzymatic extracts from a brown seaweed Ecklonia cava showed potent DNA protection in 383 
rat lymphocytes using the comet assay (Heo, Park, Park, Kim, & Jeon, 2005). Another study 384 
using fish gelatine hydrolysates demonstrated that DNA damage was decreased in a dose-385 
response manner in H2O2 challenged U937 cells (Karnjanapratum, O'Callaghan, Benjakul, & 386 
O'Brien, 2016). A fractionated protein hydrolysate from brewers' spent grain (BSG) with a 387 
molecular mass <5 kDa was reported to decrease the DNA damage in U937 cells treated with 388 
H2O2 (McCarthy et al., 2013). The authors stated that the genoprotective effect of 389 
unfractionated BSG samples was lower than their correspondent fractionated samples. This 390 
suggests that further fractionation of the present hydrolysate samples may be of interest to 391 
assess specific peptide effects on cellular DNA damage. 392 
 393 
3.5. In vitro antioxidant assays 394 
 395 
The chemical antioxidant activity of intact NaCN, the TGase treated NaCN and non-396 
TGase-treated NaCN hydrolysates was determined using four different assays. ORAC, DPPH 397 
and ABTS are radical scavenging assays whereas FRAP is based on the ability of the test 398 
compound to reduce ferric ions. The results obtained are shown in Fig. 2. The three 399 
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hydrolysate preparations (Prolyve, TGase/Prolyve and Prolyve/TGase) had significantly 400 
higher (p < 0.05) ORAC activity than unhydrolysed NaCN. The highest mean ORAC value 401 
(887.1 ± 52.6 µmol TE g-1) was found in Prolyve/TGase although no significant differences 402 
were found between the three hydrolysates. A similar trend was observed using the FRAP 403 
assay. The NaCN hydrolysates showed significantly higher FRAP values (23.02, 24.56 and 404 
22.95 µM for Prolyve, TGase/Prolyve and Prolyve/TGase, respectively) than untreated casein 405 
(6.29 µM). But again, no differences were found whether the samples were TGase treated or 406 
not. FRAP is an antioxidant assay that measures the ability of the hydrolysates to reduce Fe3+ 407 
to Fe2+. The ion is captured and the chain reaction of the oxidation process does not occur. 408 
FRAP values are relatively high in whey proteins. Bagheri, Madadlou, Yarmand, and 409 
Mousavi (2014) reported, using the ferric reducing power assay, that cross-linked whey 410 
hydrolysates had higher antioxidant activity than those non-cross-linked or intact whey 411 
protein. According to Bagheri et al. (2014) cross-linking was responsible for creating peptide 412 
structures with the ability of neutralise the ion radicals. However, the results herein 413 
demonstrate that the TGase treatment did not affect the FRAP values obtained for TGase-414 
treated NaCN hydrolysates. The FRAP and H2O2-induced DNA damage (Comet assay) 415 
assays are both related to an iron-dependent mechanism. Although it was previously shown 416 
that the Prolyve hydrolysate had a significant effect on the protection of H2O2-induced DNA 417 
damage, the FRAP results showed no difference between non-TGase-treated (Prolyve) and 418 
TGase-treated hydrolysates (TGase/Prolyve and Prolyve/TGase). This may be caused by the 419 
participation of different components or behaviors of the cells such as enzymatic complexes 420 
or cell uptake that could influence the antioxidant response and show diverse results than the 421 
in vitro chemical assays (López-Alarcón & Denicola, 2013). DPPH and ABTS inhibition 422 
showed no significant differences (p > 0.05) between the hydrolysates and intact casein. 423 
DPPH is a proton-radical scavenging assay. Some studies have previously shown the 424 
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potential of casein hydrolysates to scavenge DPPH radical ions (Suetsuna, Ukeda, & Ochi, 425 
2000). However, the hydrolysates generated in the present study were not found to possess 426 
DPPH scavenging activity in comparison with Trolox and ascorbic acid. Similar results for 427 
NaCN hydrolysates were reported by Lahart et al. (2011). The DPPH assay uses methanol or 428 
ethanol as solvent. Previous studies determined that the hydrolysate samples generated herein 429 
had a hydrophilic profile (data not shown), which may be the reason for the negative results. 430 
A method based on an aqueous system, ABTS+ assay, was then performed. However, the 431 
results showed that the activity of the hydrolysates against ABTS+ radical ranged between 6.4 432 
and 8.4 % inhibition and none of the hydrolysates showed significant differences with NaCN. 433 
A study on the antioxidant activity of different amino acids assessed by the ABTS+ assay, 434 
reported that Cys was the most active amino acid followed by Trp, Tyr and His (Aliaga & 435 
Lissi, 2000). These specific amino acids are not present in large amounts in caseins. 436 
Therefore, based on the results and the amino acid composition of casein it would appear that 437 
the DPPH and ABTS+ assays may not be adequate methods to quantify the antioxidant 438 
potential of casein hydrolysates. It is been reported that the combination of 439 
glycosylation/glycation and TGase may increase the antioxidant properties of fish gelatin 440 
hydrolysates (Hong et al., 2014). The TGase/treated glycopeptides were shown to inhibit lipid 441 
oxidation of linoleic acid and to increase the cellular antioxidant activity in HepG2 cells 442 
using the DCFH-DA method. However, the study was performed using guinea pig TGase and 443 
Alcalase. The authors also explained that the glycosylation/glycation process could be an 444 
enhancer of the antioxidant properties of the hydrolysates.  445 
 The results shown herein demonstrate that casein hydrolysates may be a good source 446 
of antioxidant hydrolysates. However, treatment with TGase prior to or post hydrolysis with 447 
Prolyve does not seem to exert any significantly difference on the antioxidant activity of the 448 
hydrolysates. This was consistent across the in vitro antioxidant assays employed herein. 449 
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 450 
4. Conclusion 451 
 452 
The findings from the present study show that casein derived peptides may exert 453 
specific antioxidant and anti-inflammatory effects. The hydrolysates possessed a higher 454 
ORAC and FRAP antioxidant activity in comparison with the unhydrolysed NaCN but the 455 
results suggest that the addition of TGase prior to or followed hydrolysis does not change the 456 
antioxidant activity of the hydrolysates. The non-TGase-treated hydrolysate sample Prolyve, 457 
demonstrated genoprotective activity against H2O2 induced DNA damage. On the other hand, 458 
the hydrolysates generated with the addition of TGase prior to and after hydrolysis showed a 459 
significant decrease in the release of IL-6 cytokine at low concentrations, corresponding to an 460 
anti-inflammatory activity. The fractionation and isolation of peptides from these bioactive 461 
hydrolysates is the next step to obtain potent immunomodulatory or antioxidant peptides and 462 
to incorporate them into functional foods. 463 
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Figure legends 
 
Fig. 1. DNA damage (%) in the U937 cell line after incubation with (a) t-BOOH (400 µM) 
and (b) hydrogen peroxide (50 µM). In each graph, different letters denote significant 
differences between samples at p < 0.05 (n=4). Control - : non-treated cells. 
Fig. 2. In vitro antioxidant activities of sodium caseinate (NaCN) hydrolysates against: (a) 
oxygen radical absorbance capacity assay (ORAC, in µmol TROLOX eq g-1); (b) ferric 
reducing antioxidant power (FRAP) activity; (c) 2,2-diphenyl-1-picrylhydrazyl (DPPH) 
inhibition; (d) 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonate) (ABTS+) inhibition. 
Different letters denote significant differences between samples within each graph at p < 0.05 
(n=3). 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Table 1 
Effect of sodium casein (NaCN), NaCN non-cross-linked hydrolysate (Prolyve) and NaCN 
transglutaminase (TGase) cross-linked hydrolysates (TGase/Prolyve and Prolyve/TGase) on 
cell viability in the Jurkat T cell line.a 
 
a Cells were exposed to increasing concentrations (0.25–50 mg mL-1) of samples for 24 h and 
cell viability was determined by the MTT assay. Data represent the mean ± SE of at least 
three independent experiments expressed as a percentage relative to untreated cells. An 
asterisk indicates statistically significant difference (p < 0.05) in cell viability between 
control (untreated) and treated cells.  
 
 
 
 
 
 
 
 
  
Concentration 
(%, v/v) 
NaCN Prolyve TGase/Prolyve Prolyve/TGase 
Control 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.025 94.36±6.42 91.40±2.06 95.24±5.56 86.14±3.53 
0.05 88.18±5.65 89.61±1.27 87.29±3.49 85.22±2.70* 
0.1 80.60±8.65* 90.34±1.17 83.78±2.28 75.69±3.51* 
0.5 68.47±4.55* 77.59±5.40* 68.22±4.02* 76.10±4.16* 
1.0 72.35±5.56* 82.80±6.65 80.80±7.82 81.07±4.34 
2.0 59.79±0.55* 59.38±7.50* 47.46±8.71* 54.16±8.73* 
5.0 18.85±5.53* 25.70±16.18* 8.56±0.32* 10.55±1.67* 
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Table 2 
Effect of sodium casein (NaCN), NaCN non-cross-linked hydrolysate (Prolyve) and NaCN 
transglutaminase (TGase) cross-linked hydrolysates (TGase/Prolyve and Prolyve/TGase) on 
cell viability in the U937 cell line. a 
 
a Cells were exposed to increasing concentrations (0.25–50 mg mL-1) of samples for 24 h and 
cell viability was determined by the MTT assay. Data represent the mean ± SE of at least 
three independent experiments expressed as a percentage relative to untreated cells. An 
asterisk indicates statistically significant difference (p < 0.05) in cell viability between 
control (untreated) and treated cells.  
 
 
 
 
 
  
Concentration 
(%, v/v) 
NaCN Prolyve TGase/Prolyve Prolyve/TGase 
Control 100.00±0.00 100.00±0.00 100.00±0.00 100.00±0.00 
0.025 99.46±2.02 108.88±1.74* 102.04±2.04 95.19±2.81 
0.05 102.21±4.00 112.35±3.47 107.29±7.43 95.47±9.26 
0.1 93.52±3.64 116.15±5.50 103.78±3.03 105.37±6.25 
0.5 100.70±4.46 117.87±2.35 106.96±8.12 106.22±4.26 
1.0 91.99±1.53 81.93±4.16 98.39±8.39 79.97±5.44* 
2.0 70.60±3.37* 15.34±3.90* 51.98±12.01* 25.02±7.78* 
5.0 28.65±2.45* 12.69±1.46* 14.09±1.43* 13.94±1.48* 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 3 
EC50 values of sodium casein (NaCN), NaCN non-cross-linked hydrolysate (Prolyve) and 
NaCN transglutaminase (TGase) cross-linked hydrolysates (TGase/Prolyve and 
Prolyve/TGase). a 
 
Sample EC50 (mg mL-1) 
  Jurkat T U937 
NaCN 18.65ac 31.55a 
Prolyve 30.55b 13.96b 
TGase/Prolyve 16.02ac 21.58c 
Prolyve/TGase 22.92abc 14.94bc 
 
a
 Values are mean of at least three independent experiments. Different superscript letters 
denote significant difference (p < 0.05) for each cell line. EC50 values represent the 
concentration of sample that inhibits 50% of cell proliferation. 
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Table 4 
 
Effect of sodium casein (NaCN), NaCN non-cross-linked hydrolysate (Prolyve) and NaCN 
transglutaminase (TGase) cross-linked hydrolysates (TGase/Prolyve and Prolyve/TGase) on 
IL-2 and IL-6 cytokine production in Concanavalin (ConA) stimulated Jurkat T cells. a 
 
Sample Cytokine production (% of control) 
IL-2  IL-6 
0.5 mg mL-1  1 mg L-1  0.5 mg mL-1  1 mg mL-1 
Mean SE  Mean SE  Mean SE  Mean SE 
Control 100.00 a 0.00  100.00 a 0.00  100.00 a 0.00  100.00 a 0.00 
NaCN 107.41 a 9.41  79.00 b 3.35  41.85 b 2.82  30.21 b 6.90 
Prolyve 98.49 a 2.72  93.18 a 4.71  88.78 ac 2.05  80.79 c 2.03 
TGase/Prolyve 106.17 a 3.14  98.38 a 5.21  85.45 c 2.85  78.12 c 1.94 
Prolyve/TGase 101.91 a 2.98  96.94 a 3.44  83.91 c 3.71  79.80 c 4.81 
 
 
a
 Values are mean ± SE of at least 3 independent experiments, expressed as a percentage 
relative to the control (non-treated ConA stimulated cells). Different superscript letters denote 
significant differences (p < 0.05) in cytokine production between samples. 
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Table 5 
Glutathione (GSH) content of U937 cells exposed to sodium casein (NaCN), NaCN non-
cross-linked hydrolysate (Prolyve) and cross-linked hydrolysates (TGase/Prolyve and 
Prolyve/TGase). a 
Sample GSH content 
Control 100.0±0.0  
NaCN 72.1±14.7  
Prolyve 111.1±18.6  
TGase/Prolyve 134.1±21.8  
Prolyve/TGase 130.8±21.7 
 
a
 Data are the mean of three independent experiments ± SE; none of the results was statistically 
significant compared with the untreated cells.  
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Figure 1.  
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Figure 2.  
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